Prelude Therapeutics Inc Company Profile
Overview - Prelude Therapeutics
We are a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients.
Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients.
Investor Relations - Prelude Therapeutics
Corporate Profile. Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients.
Prelude Therapeutics Inc - Company Profile and News
Company profile page for Prelude Therapeutics Inc including stock price, company news, executives, board members, and contact information.
Prelude Therapeutics Company Profile 2024 - PitchBook
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies.
Prelude Therapeutics Inc Company Profile - Overview - GlobalData
Prelude Therapeutics Inc company profile analysis with the premuim data - Globaldata.
PRLD | Prelude Therapeutics Inc. Company Profile & Executives - WSJ
Company profile for Prelude Therapeutics Inc. including key executives, insider trading, ownership, revenue and average growth rates.
Prelude Therapeutics | LinkedIn
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways.
Prelude Therapeutics - Crunchbase Company Profile & Funding
Legal Name Prelude Therapeutics Inc. ... cancer, enabling healthcare providers to discover potential treatments that offer hope to people with cancer. Prelude ...
Prelude Therapeutics Incorporated (PRLD) company profile & facts
Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to ...
Company Prelude Therapeutics Incorporated - MarketScreener
Prelude Therapeutics Incorporated is a clinical-stage fully integrated oncology company built on a foundation of drug discovery to deliver novel precision ...
Prelude Therapeutics - Company Profile - Tracxn
Prelude Therapeutics - Developer of chromatin function targeting drugs for the treatment of cancer & rare diseases. Public Company.
Prelude Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Prelude Therapeutics Inc. - BioCentury Company Profiles for the biopharma industry.
Strategic Partnerships Prelude Therapeutics has established strategic partnerships with companies such as QDX Inc., Device Authority Ltd., and AbCellera ...
Prelude Therapeutics Inc - Company Profile - GlobalData
Prelude Therapeutics company overview and more information. Prelude Therapeutics Inc (Prelude) is a clinical-stage precision oncology company developing ...
SEC Filings - Investor Relations - Prelude Therapeutics
We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
Investor FAQ's - Prelude Therapeutics
Where is Prelude Therapeutics Incorporated? Prelude ... How can I sign up to receive Prelude Therapeutics press releases and other company information?
SEC Filing - Investor Relations - Prelude Therapeutics
Utilizing our unique fully-integrated targeted oncology discovery engine, we will continue to pursue small-molecule therapies optimized to effectively target ...
Prelude Therapeutics, Inc. - Discovery PatSnap
Discovery Company profile page for Prelude Therapeutics, Inc. including technical research,competitor monitor,market trends,company profile& stock symbol.
Prelude Therapeutics Email verification & Email checker
Founded in 2016 and headquartered in Newark, Delaware, Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and ...